Leap Therapeutics Inc (LPTX): $2.50 pre-market

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	115
Posts	14166
Boards Moderated	2
Alias Born	10/24/2007

wesley_

Re: Deano361 post# 211

Thursday, 09/16/2021 9:01:05 AM

Thursday, September 16, 2021 9:01:05 AM

$2.50 pre-market smile

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent LPTX News

Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/06/2024 09:31:33 PM
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/31/2024 10:29:37 PM
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/31/2024 09:40:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:29:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:29:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:27:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:26:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:25:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:24:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:24:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:23:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 11:30:29 AM
Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients • PR Newswire (US) • 09/30/2024 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:10:19 AM
Leap Therapeutics Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/12/2024 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 10:50:46 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:48:28 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/23/2024 08:25:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:10:27 AM
Leap Therapeutics Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/13/2024 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 10:50:43 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 09:01:55 PM
Leap Therapeutics Announces $40 Million Private Placement • PR Newswire (US) • 04/11/2024 12:30:00 PM

More LPTX News

InvestorsHub NewsWire

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM

Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM

SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover